Prof. Schwiertz Unveils the Role of Butyrate, Gut Microbes, and Prebiotics in Parkinson’s Disease at Targeting Microbiota 2023
Prof. Andreas Schwiertz, a distinguished researcher from the Institute of Microecology in Germany, is set to share groundbreaking discoveries at the upcoming Targeting Microbiota 2023 conference, taking place from October 17th to 19th.
In his talk, titled “Unraveling the Role of Butyrate, Gut Microbes, and Prebiotics in Parkinson’s Disease: Insights from the RESISTA-PD Trial”, Prof. Schwiertz will delve into the connections between butyrate, gut microbes, and Parkinson’s disease.
In recent years, scientists have been exploring how the health of our gut, where our body’s microbes live, affects different illnesses like Parkinson’s disease (PD). They’ve noticed that people with PD often have fewer microbes that make short-chain fatty acids (SCFAs) in their gut, and these SCFAs are usually lower. SCFAs are like helpers in our body.
The Study Highlights:
- Prof. Schwiertz and colleagues did an 8-week study with people who have PD.
- Some people took a special kind of food called resistant starch (RS).
- People who ate this food had more of a special SCFA called butyrate in their gut.
- They also had lower levels of a substance called calprotectin in their gut.
- They seemed to have fewer problems that aren’t related to moving (we call these non-motor problems).
About Prof. Andreas Schwiertz:
Prof. Schwiertz is a smart scientist who studied at different schools in Germany, Ireland, and Russia. He got his PhD in Germany, where he learned about the tiny living things in our gut with Prof. Michael Blaut. He’s now a teacher at the Justus Liebig University of Giessen and the head of the Institute of Microecology in Herborn.
We welcome you to be part of the Targeting Microbiota 2023 conference to learn more from Prof. Schwiertz’s talk. Registration Details.
Targeting Microbiota 2023 Congress
October 17-19, 2023
LinkedIn | Facebook
